Studies in several laboratories have clearly established that the RNA segments contained in influenza virus particles must first be transcribed into complementary (c) RNA before translation on polysomes can occur (5-7, 12, 17, 25, 34) . However, the enzymatic processes and the specific proteins required for the transcription into cRNA and replication of virion RNA have not been fully characterized. Chow and Simpson (4) were the first to describe polymerase activity in purified influenza virus particles. Subsequent biochemical analysis of the transcriptase-positive ribonucleoprotein complex of WS (2) and WSN viruses (30) and of a nucleocapsid fraction from infected cells (3) revealed the presence of P1 and possibly P2 proteins as well as a nucleoprotein, which suggested that any one or all of these three proteins might be required for cRNA synthesis. More recently, a third virus-coded P protein was identified in virus particles and in influenza virus-infected cells in our laboratory (18, 28, 29) and independently by other groups (10, 15) , adding yet another virus-coded protein which might be required for transcriptase activity.
Up to now, attempts to demonstrate transcriptase activity with isolated components of the transcriptase complex have not been successful. As a result, it has not been possible to biochemically define which of the four proteins (P1, P2, P3, NP) are required for cRNA synthesis. In a previous communication (14) we reported that two of the seven temperature-sensitive (ts) mutant groups of influenza A/WSN virus described by Sugiura et al. (32, 33) had defects in cRNA synthesis. Analysis of cRNA from cells infected with mutant virus from different groups revealed that only members of mutant groups I and III failed to synthesize cRNA at the nonpermissive temperature or after shift from the permissive to the nonpermissive temperature.
These observations suggested that at least two of the gene products in the ribonucleoprotein core are required for cRNA synthesis. In the present communication, we describe how the analysis of RNAs of recombinants derived from influenza A/HK/8/68 and ts mutants in groups I and III permits us to establish that the specific defects of these groups are in P3 and P1 proteins, respectively, and to deduce that these two proteins are required for cRNA synthesis.
MATERIALS AND METHODS Cells and viruses. MDBK (bovine kidney) and MDCK (canine kidney) cells were grown as previously described (13, 32, 33 (18, 19, (21) (22) (23) (27) (28) (29) . RESULTS RNA analysis of ts mutants. In a previous communication we identified two ts mutant groups of influenza WSN virus which had defects in genes required for the synthesis of cRNA in vivo (14) . Mutants in group I later were shown to possess a thermolabile transcriptase in vitro (16) . Preliminary experiments also revealed that mutants in these groups (I and III) direct little or no virus-specific protein synthesis when grown at the nonpermissive temperature (K. Tobita, M. Ueda, R. M. Krug, and P. Palese, unpublished observations). In addition, it was found that virusspecific proteins made by these mutants at permissive temperature did not differ from those made by the wild-type virus when analyzed on gradient polyacrylamide gels.
However, the analysis of the RNAs of ts mutants and the wild-type virus revealed differences in some instances. Figure 1 demonstrates that the slowest moving RNA (RNA 1) of tsl (group I) moves faster than the corresponding RNA of the wild-type virus (arrow). A second mutant in group I (ts6) and tslO1 (group III) had RNA patterns that were indistinguishable from that of the wild-type virus (results not shown). But another mutant (ts15, group III) also contained one RNA segment (RNA 2) that differed in its migration rate from the equivalent segment of wild-type virus (Fig. 2, arrow) . tsl and ts15 were obtained after chemical mutagenesis of the wild-type virus with 5-fluorouracil (32) , and differences in the migration rate of individual RNAs in the two mutants undoubtedly reflect mutations in these genes. However, there was no proof that mutations detectable by polyacrylamide gel electrophoresis corresponded to the lesions responsible for the ts defects, and independent evidence had to be provided to verify that mutants in groups I and III have ts lesions in RNA 1 and RNA 2, respectively.
Selection of wild-type recombinants. Figure  3 schematically shows the approach that was taken to identify the ts genes of mutant viruses. Cells were simultaneously infected with mutants, and HK virus and recombinants were selected at nonpermissive temperature. Infection with ts mutants was done at a high multiplicity, and infection with HK virus was done at a low multiplicity to permit the selection of viable recombinants, in which most of the genes were derived from WSN virus. Similar procedures to obtain recombinants, which derive most of the genes from one or the other parent have been described previously (31) . RNA analysis of the ts+ recombinants allowed the identification of genes that were derived from HK virus and thus replaced the ts genes of the mutant viruses.
Mapping of WSN virus genome. To identify the defective gene products of ts mutants of WSN virus, it was first necessary to establish a genetic map of the wild-type virus. This was accomplished by selection of recombinants derived from wild-type A/WSN virus and from the influenza A/HK/8/68 virus we had previously mapped (18, 22, 28, 29) . For example, recombinants containing only the neuraminidase from WSN virus were shown to contain only RNA 6 from WSN virus, whereas all other RNAs were derived from HK virus (gel not shown); hence RNA 6 codes for neuraminidase. Similar analysis permitted the identification of the gene products of RNAs 1 through 8 ( Fig. 1  and 2 ). It can be seen that the gene order of WSN virus is identical to that of influenza A/ PR/8/34 virus, another virus with the HON1 serotype (18, 22, 28, 29 (26) . Therefore, the possibility that mutants in groups I and III have a ts defect in RNA 7 (M protein) can be excluded. All attempts to select ts+ recombinants of ts6, another group I mutant, and HK virus failed. The reasons for this are not clear, but it appears that HK virus interferes with the replication of ts6 (unpublished observation).
As noted previously, the fact that RNA 2 of (32, 33) . Therefore, it is highly unlikely that mutants in groups I and III have an additional ts defect other than those in RNA 1 or 2. Using information obtained from maps of the WSN and HK virus genomes, we conclude that group I mutants have ts defects in P3 protein and group III mutants are defective in P1 protein. Because the ts defects in members of both of these groups result in the absence of RNA synthesis at the nonpermissive temperature, we further conclude that functional P1 and P3 proteins are required for cRNA synthesis.
Based on the identification of the specific ts defects in other mutant groups (24, 26, 35) and characterization of their biological properties (14, 32, 33) , it is unlikely that either of the surface proteins or M, NP, and P2 proteins directly influence or regulate transcriptase activity in vivo. It is obvious that the nonstructural protein (NS) is not involved in the in vitro transcriptase activity of purified virus. However, unless mutants defective in nonstructural protein are identified, the possibility that nonstructural protein has a regulatory function during transcription in vivo will remain open.
Finally, several other questions remain unaswered at this time. Although actinomycin D has no effect on in vitro transcriptase activity (4), cRNA synthesis in vivo is inhibited by this drug. Furthermore, no viral protein synthesis takes place in enucleated cells (9, 11) , and cRNA made in vitro is not translated in a cellfree wheat germ system (M. B. Ritchey and P.
Palese, unpublished observation). These observations suggest that there are additional host factors which may be required for the synthesis of biologically active viral mRNA's.
In conclusion, our data indicate that P1 and P3 protein have an essential role during cRNA synthesis of influenza virus, but additional factors may be required for a biologically active transcriptase complex in vivo.
